Myomo (MYO) Non-Current Assets (2016 - 2025)
Myomo (MYO) posted Non-Current Assets of $11.1 million for Q4 2025, little changed on a QoQ basis from $11.1 million in Q3 2025, and up 17.19% year-over-year from $9.5 million in Q4 2024.
Myomo (MYO) Non-Current Assets (2016 - 2025) Analysis & Trends
Myomo's Non-Current Assets history runs 10 years deep, the most recent figure standing at $11.1 million for Q4 2025.
- Quarterly Non-Current Assets rose 17.19% year-over-year to $11.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $42.6 million (up 229.59% YoY) and the FY2025 annual result came in at $11.1 million, up 17.19% from the prior year.
- Non-Current Assets was $11.1 million for Q4 2025 at Myomo, roughly flat from $11.1 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $11.1 million in Q3 2025 and bottomed at $666644.0 in Q2 2023.
- A 5-year average of $3.4 million and a median of $1.1 million in 2021 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2023 — Non-Current Assets slumped 46.93% — and 2025, when it jumped 1097.65%.
- Myomo's Non-Current Assets stood at $1.0 million in 2021, then fell by 5.68% to $946549.0 in 2022, then declined by 1.69% to $930585.0 in 2023, then jumped by 915.93% to $9.5 million in 2024, then gained by 17.19% to $11.1 million in 2025.
- Business Quant data shows MYO's Non-Current Assets at $11.1 million in Q4 2025, $11.1 million in Q3 2025, and $10.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | 11.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.08 Mn |
| Sep 30, 2025 | 11.13 Mn |
| Jun 30, 2025 | 10.63 Mn |
| Mar 31, 2025 | 9.77 Mn |
| Dec 31, 2024 | 9.45 Mn |
| Sep 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 815,769.00 |
| Dec 31, 2023 | 930,585.00 |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 666,644.00 |
| Mar 31, 2023 | 823,972.00 |
| Dec 31, 2022 | 946,549.00 |
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 1.26 Mn |
| Mar 31, 2022 | 1.37 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | 998,455.00 |
| Jun 30, 2021 | 1.08 Mn |
| Mar 31, 2021 | 994,112.00 |